President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...

Jordan, represented by the Jordan Food and Drug Administration (JFDA), has been granted full membership in the Pharmaceutical Inspection Co-operation Scheme (PIC/S), becoming the second Arab nation to ...

Having seen Congress spend money to onshore semiconductor production, pharma groups are pushing for similar incentives for ...

Developers of biosimilars, medicines that are near-identical copies of biologic drugs, will no longer be required to conduct clinical trials to prove effectiveness.

The official, Dr. George F. Tidmarsh, a top regulator at the agency, said disagreements over a new program to rapidly approve medications had caused tensions with agency officials.

An Australian manufacturer at the centre of the sunscreen scandal repeatedly failed to follow manufacturing standards during ...

The agency will no longer require studies comparing copycat biologics to their branded counterparts, which could help ...

The U.S. Food and Drug Administration has flagged three of Philips' medical device facilities after inspections found they ...

Kemwell’s FDA-approved site features single-use and stainless-steel bioreactors, with over 5000L+ of installed upstream capacity, commercial fill-finish lines for liquid and lyophilized vials, and pre ...

A top medic has warned of the strong possibility of Ugandans facing higher costs of health care due to a spike in the price ...

Milestone expands India's role in global biologics manufacturing; collaboration with Cipla underscores commitment to quality and reliability Kemwell Biopharma Pvt Ltd ("Kemwell"), a leading global ...